MENU
+Compare
THRD
Stock ticker: NASDAQ
AS OF
Jan 31, 11:52 AM (EDT)
Price
$5.37
Change
+$0.02 (+0.37%)
Capitalization
234.3M

THRD Third Harmonic Bio Forecast, Technical & Fundamental Analysis

Industry Biotechnology
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for THRD with price predictions
Jan 29, 2025

THRD's RSI Indicator is remaining in oversold zone for 12 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

THRD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on THRD as a result. In of 48 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for THRD turned negative on January 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 19 similar instances when the indicator turned negative. In of the 19 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THRD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for THRD entered a downward trend on January 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.818) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). THRD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. THRD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

THRD is expected to report earnings to rise 7.58% to -35 cents per share on March 26

Third Harmonic Bio THRD Stock Earnings Reports
Q4'24
Est.
$-0.35
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.11
Q4'23
Beat
by $0.14
The last earnings report on November 07 showed earnings per share of -33 cents, missing the estimate of -29 cents. With 2.34K shares outstanding, the current market capitalization sits at 234.30M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Montgomery Street
Phone
+1 209 727-2457
Employees
30
Web
https://www.thirdharmonicbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGVX17.910.20
+1.13%
T. Rowe Price Glbl Val Eq
JPPEX66.820.74
+1.12%
JPMorgan Mid Cap Equity R6
NSNRX49.70N/A
N/A
Neuberger Berman Small Cap Growth R3
MCILX18.19N/A
N/A
BlackRock International Inv C
MSDOX12.20N/A
N/A
Morgan Stanley Emerging Mkt ex China C

THRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with INZY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
+2.88%
INZY - THRD
46%
Loosely correlated
+2.82%
NVAX - THRD
42%
Loosely correlated
+2.27%
PRME - THRD
41%
Loosely correlated
+2.91%
NTLA - THRD
41%
Loosely correlated
+3.85%
ACLX - THRD
39%
Loosely correlated
+4.65%
More